https://tissuepathology.com Educational and informative Tue, 19 May 2026 12:26:00 +0000 en-US hourly 1 https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png https://tissuepathology.com 32 32 https://tissuepathology.com/2026/05/19/astrazeneca-collaborates-with-roche-diagnostics-asia-pacific-to-help-accelerate-sustainable-ecosystem-for-advanced-pathology-in-breast-and-lung-cancer/ Tue, 19 May 2026 12:26:00 +0000 https://tissuepathology.com/?p=24425 SINGAPORE, May 18, 2026 /PRNewswire/ — AstraZeneca and Roche Diagnostics Asia Pacific today announced a three-year Memorandum of Understanding to help advance digital pathology capabilities and elevate cancer care across nine Asia markets, a first in the region. This landmark collaboration aims to accelerate the adoption of AI-powered digital and computational pathology through educational and training initiatives and improve […]

The post AstraZeneca Collaborates with Roche Diagnostics Asia Pacific to Help Accelerate Sustainable Ecosystem for Advanced Pathology in Breast and Lung Cancer first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/05/07/roche-enters-into-a-definitive-merger-agreement-to-acquire-pathai-to-transform-ai-driven-diagnostics/ Thu, 07 May 2026 13:26:42 +0000 https://tissuepathology.com/?p=24403 PathAI’s best-in-class Image Management System (IMS) with advanced AI analysis and workflow capabilities will complement Roche’s digital pathology portfolio to drive laboratory efficiency Combining Roche’s strong position in companion diagnostics and PathAI’s advanced AI platform helps accelerate clinical therapy development, foster the discovery of new biomarkers, and create novel diagnostic tools These integrated capabilities will […]

The post Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/05/04/connect-with-deciphex-in-dublin/ Mon, 04 May 2026 12:25:23 +0000 https://tissuepathology.com/?p=24394 From Deciphex on LinkedIn: Next Tuesday, our CEO Donal O’Shea takes the stage at the MedTech Strategist Innovation Summit in Dublin. Donal will be joining the “Breaking In: Rolling out Medtech in Europe” commercialisation panel, sharing the hard-won perspective that comes from building and scaling AI-driven digital pathology across some of the world’s most complex […]

The post Connect with Deciphex in Dublin! first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/04/29/evident-announces-6th-annual-image-of-the-year-award-winners/ Wed, 29 Apr 2026 13:25:16 +0000 https://tissuepathology.com/?p=24385 EVIDENT: Star-like neurospheres brilliantly connect our inner and outer worlds NEEDHAM, Mass., April 28, 2026 (GLOBE NEWSWIRE) — Evident unveiled the winners of its sixth annual Image of the Year contest, an awards competition that recognizes the world’s best in scientific microscopic imaging. The winners were selected from submissions from 34 countries around the world. Global […]

The post EVIDENT Announces 6th Annual Image of the Year Award Winners first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/04/28/histoindex-extends-access-to-its-mash-diagnostic-offering-through-new-partnerships-in-texas-and-california/ Tue, 28 Apr 2026 11:50:17 +0000 https://tissuepathology.com/?p=24383 SINGAPORE, April 28, 2026 /PRNewswire/ — HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced the continued expansion of its commercial partnership network in the United States with the addition of two new hepatology and gastroenterology centers – Houston Research Institute (HRI) Kingwood and Knowledge Research Center (KRC) in Orange, California. HistoIndex […]

The post HistoIndex Extends Access To Its MASH Diagnostic Offering Through New Partnerships In Texas And California first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/04/27/fimlab-expands-utilization-of-aiforias-clinical-ai-solutions/ Mon, 27 Apr 2026 12:10:53 +0000 https://tissuepathology.com/?p=24380 Fimlab Laboratories expands the use of Aiforia’s AI solutions for breast cancer diagnostics, bringing multi-organ Ki67 biomarker quantification into routine clinical use. Aiforia Technologies Plc, Press Release, April 27, 2026 at 9:00 a.m. EEST Aiforia Technologies Plc announced today that Fimlab Laboratories in Finland has expanded the use of Aiforia’s AI solutions in routine clinical […]

The post Fimlab expands utilization of Aiforia’s clinical AI solutions first appeared on Tissuepathology.com.]]>